Prescription Drug

A woman filed a federal class action against Amag Inc., claiming its <a href="http://www.courthousenews.com/wp-content/uploads/2019/11/Prescription-Drug.pdf"><strong>high-priced drug Makena</strong></a> (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

JOPLIN, Mo. — A woman filed a federal class action against Amag Inc., claiming its high-priced drug Makena (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

Categories / Consumers, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.